Company Search:
Advanced Search
Sponsored Links
Helixmith Co Ltd Company Snapshot
Helixmith Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Helixmith Co Ltd with three other companies in this sector in KOREA (SOUTH) : Bio Solution Co Ltd (2020 sales of 7.74 billion Korean Won [US$6.88 million] of which 54% was Cell Therapy Products), Pharma Research Bio Co Ltd (6.31 billion Korean Won [US$5.60 million] ), and Peptron Inc (3.12 billion Korean Won [US$2.77 million] of which 54% was Biotechnology).

Sales Analysis. Helixmith Co Ltd reported sales of 4.30 billion Korean Won (US$3.82 million) for the year ending December of 2020. This represents a decrease of 3.4% versus 2019, when the company's sales were 4.45 billion Korean Won .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Helixmith Co Ltd
  Stock Performance Chart for Helixmith Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/30/2021): 31,150
(Figures in Korean Won )
1 Week 9.1%   13 Weeks 18.7%  
4 Weeks 21.4%   52 Weeks -53.2%  
Helixmith Co Ltd Key Data:
  Ticker: 084990 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 4,304,348,896
(Year Ending Jan 2021).
Employees: 57
  Currency: Korean Won Market Cap: 1,066,455,324,900
  Fiscal Yr Ends: December Shares Outstanding: 34,236,126
  Share Type: Common Closely Held Shares: 3,284,466
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.